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What’s Known on This Subject:
Type 1 diabetes is increasing in 
children both nationally and in West 
Virginia. Vitamin D supplementation 
early in life has been shown 
to be protective against the 
development of type 1 diabetes.
What This Study Adds:
Our systematic literature review 
gathers an overwhelming amount of 
evidence regarding the relationship 
of Type 1 diabetes and vitamin 
D supplementation. By doing so 
we are able to encourage further 
study to clarify the effective 
dosage of supplementation 
and to emphasize the potential 
benefits of providing currently 
recommended supplementation.
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Abstract
Vitamin D deficiency is associated 
with multiple childhood diseases 
including type 1 diabetes mellitus 
(T1DM). T1DM in children is 
becoming more prevalent, with a 23% 
increase nationally from 2001 to 2009. 
Similarly, West Virginia has had an 
8.1% increase in children with type 1 
Diabetes from 2008/2009 to 2010/2011. 
This article highlights the association 
between vitamin D and type 1 diabetes 
and discusses vitamin D’s potential 
role in the reduction and management 
of T1DM in children. 
Introduction
The incidence of type 1 diabetes 
mellitus (T1DM) in children rose 
23% nationally between 2001 and 
2009.1 More recently, West Virginia’s 
T1DM in children dramatically rose 
8.1% from 2008/2009 to 2010/2011.2 
T1DM is an autoimmune disease 
that results in the destruction of 
pancreatic beta cells, resulting 
in insulin dependence. Multiple 
genes and environmental 
factors have been implicated in 
triggering the onset of T1DM.3 
A large case control study by the 
EURODIAB group suggests that 
regular vitamin D supplementation 
in childhood can help prevent the 
development of T1DM characterized 
by a progressive autoimmune 
destruction of pancreatic beta 
cells.4 Exact mechanisms that 
confer this protection are not 
defined but studies suggest that 
the biologically active form of 
vitamin D – 1, 25 hydroxyvitamin 
D3 – is an immunomodulator.5,6 
Vitamin D supplementation 
reduces lymphocyte proliferation 
and promotes a shift of type 1 
T helper to type 2 T helper cell 
immune response.5,6 Therefore, 
a deficiency of vitamin D may 
predispose the beta cells to 
autoimmune destruction.7-9 
Vitamin D deficiency is common 
among chronic and newly diagnosed 
type 1 diabetics.10 Since vitamin 
D levels are affected by sun 
exposure, the fact that multiple 
studies showed that T1DM is more 
commonly diagnosed in winter 
would support an association.10,11 
Studies have also shown a positive 
correlation between latitude and 
T1DM diagnosis.11,12 For West 
Virginia, our location increases our 
risk of vitamin D deficiency because 
little if any cutaneous production 
of vitamin D occurs from mid-
October to mid-March.12,13 It is worth 
noting that living in a temperate 
climate does not automatically 
confer potential protection against 
T1DM because sufficient vitamin 
D levels are needed for protective 
benefits.14,15 To account for these 
geographic differences, multiple 
groups have recommended vitamin 
D supplementation. The American 
Academy of Pediatrics (AAP) in 2008 
increased their recommendation for 
vitamin D supplementation to 400 
IU per day for all children beginning 
in infancy.16 Compliance with these 
recommendations is concerning with 
less than half of infants and children 
receiving this amount of vitamin D.17
This article further explores the 
literature as it pertains to three 
aspects of vitamin D and type 1 
diabetes. First it considers the 
finding of vitamin D deficiency at 
the time of diagnosis of type 1 
diabetes. Second, potential effects 
of vitamin D in the prevention of 
type 1 diabetes are considered. 
Finally, the possible importance 
of vitamin D supplementation in 
already diagnosed individuals 
with T1DM is examined.
Methods
The National Library of Medicine 
Medline database was systematically 
searched through May 31, 2013 
for vitamin D and type 1 diabetes 
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in children. Search terms included 
“type 1 diabetes”, “vitamin D 
deficiency”, and “childhood vitamin 
D supplementation.” This search 
resulted in 71 articles which were 
then screened by all four authors 
in order to eliminate those dealing 
with animal studies, adults, type 
2 diabetes, genomic analysis and 
other diseases such as asthma and 
atopic dermatitis. This resulted in 
a total of 17 articles remaining that 
were specific to vitamin D and type 
1 diabetes in children (ages 0-20). 
All 17 of these articles are listed in 
Table 1 and include meta-analyses, 
other systematic literature reviews, 
birth cohort studies, case control 
studies, randomized control studies 
and observational studies. Table 1 
details each article in regard to the 
author, year, design, and findings. 
Results
An association between vitamin 
D deficiency and the diagnosis of 
T1DM was apparent in multiple 
studies. A German study of 49 newly 
diagnosed type 1 diabetics within 
48 hours of initial hospitalization 
showed that there was a significant 
decrease of 1,25 hydroxyvitamin 
D3 or 1,25(OH)2D3 in the subjects 
compared to controls without 
disease (39±2 vs. 55±4 pg/ml).18 A 
study of 170 young Qatari children 
and 170 case controls demonstrated 
an association between lower 
levels of Vitamin D and T1DM. 
There was a significant difference 
found in the mean level of vitamin 
D (p= 0.0009).15 A Swedish study 
investigated 459 young adults with 
newly diagnosed T1DM at the time 
of diagnosis, as well as 138 of those 
subjects 8 years later. The levels of 
plasma 25-hydroxyvitamin D was 
significantly lower in type 1 diabetics 
than in controls at diagnosis (82.5 
vs. 96.7 nmol/l; p<0.0001) and 
eight years later plasma levels had 
continued to decrease in children 
with T1DM.19 Interestingly, there 
was no relationship between the 
documented vitamin D levels and 
HgA1C suggesting that vitamin D 
has no influence on blood glucose 
control. On a similar note, another 
study aimed to assess whether the 
degree of diabetic control has an 
association with Vitamin D. Patients 
with established T1DM were 
categorized as either controlled or 
poorly controlled diabetics and the 
level of Vitamin D was not found to 
be significantly different. 20 A study 
in Italy revealed lower levels of 
both 1,25 – (OH)2D3 and 25-(OH)
D3 in 88 newly diagnosed type 1 
diabetics compared to controls living 
in the same geographical areas.6 
Similarly a Northern Indian study 
evaluated the Vitamin D levels of 
50 recently diagnosed children.14 
The mean levels of vitamin D were 
significantly lower in these cases 
(20.02±10.63 ng/ml, 50.05±26.57 
mmol/l) compared with the 50 
control children. Of these children 
with significantly low Vitamin D 
levels, 33 (66%) had presented in 
significant ketoacidosis. Contrary 
to the multiple studies showing 
an inverse association between 
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REFERENCE AUTHOR YEAR DESIGN FINDINGS
4 EURODIAB Study 
Group
1999 Case control 
study
•	7 centers in Europe studied 820 T1DM patients aged birth 
to 14 and 2335 controls
•	Found Vitamin D supplementation in infancy was 
associated with a decreased risk of developing T1DM. 
Combined odds ratio of children was 0.67 
6 Pozzilli, P. et al. 2005 Surveillance 
study
•	88 consecutive newly diagnosed T1DM and in 57 healthy 
age and sex matched subjects
•	Mean levels of both 25OHD3 and 1,25OH2D3 were 
significantly lower in patients compared to controls (p<0.01 
and p<0.03, respectively)
10 Janner, M. et al. 2010 Prospective 
cross sectional 
study
•	129 diabetic youth
•	The vitamin D levels of diabetics showed marked seasonal 
fluctuations, but no relationship to diabetic control. 
11 Alemzadeh, R. 
et al.
2008 Retrospective 
Case-cohort
•	127 children and adolescents (ages 6.0-17.9 years) who 
met the criteria for obesity (BMI >95th percentile)
•	Although mean serum glucose levels and HbA1c were 
similar among groups, serum insulin levels were slightly 
highers in the hypovitaminosis D group than in the vitamin 
D-sufficient group, but did not reach statisitical significance
14 Borkar, V.V. et al. 2010 Cross 
sectional case 
control study
•	50 children aged 6-12 years within one week of diagnosis of 
T1DM and in 50 healthy children
•	Mean levels of Vitamin D were significantly lower in patients 
compared to their controls [20.02 ± 10.63 ng/ml vs. 26.16 ± 
12.28 ng/ml, p = 0.009]
15 Bener, A. et al. 2009 Matched case-
control study
•	Studied 170 diabetics and 170 controls of male and female 
Qatari children (less than 16 years old)
•	Vitamin D deficiency was considerably higher in T1DM 
children (90.6%) compared to controls (85.3%)  
•	There was a significant difference found in the mean value 
of Vitamin D between T1DM and non-diabetic children 
(p=0.009). 
•	Vitamin D supplementation with breast milk was very poor 
in diabetic children (47.7%). 
•	Family history of Vit. D deficiency was higher in diabetics 
compared to non-diabetics (p<0.012). 
18 Baumgartl, H.J. 
et al.
1991 •	49 recently diagnosed diabetics were compared with 42 
healthy controls 
•	A marked decrease of 1,25OH2D3 was found at the onset 
of diagnosis compared to normal controls (p <0.01). 
•	Grouping of patients according to season demonstrated 
that the decrease of 1,25OH2D3 was present primarily 
during the summer months and likely due to a loss of 
seasonal rhythm of this hormone observed in healthy 
controls (p<0.001)
19 Littorin, B. et al. 2006 Cross 
sectional study
•	Plasma 25OHD3 levels were measured in 459 patients at 
the time of diagnosis and in 138 of those patients 8 years 
later 
•	At diagnosis, plasma 25OHD3 were signficantly lower in 
patients with T1DM than in controls (p<0.0001). 
•	8 years later, plasma 25OHD3 had decreased in patients 
(p=0.04). 
•	Plasma levels of 25OHD3 were significantly lower in 
diabetic males than females at diagnosis and followup 
(p<0.0001 and p=0.048, respectively)
Table 1.
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20 Simmons, J. et al. 2011 Cross 
sectional study
•	57 adolescents with T1DM who had HbA1c > 9% 
(unfavorable control) and <9% (favorable control). 
•	Study revealed no difference between HbA1c groups in 
Vitamin D status.
•	The prevalence of vitamin D deficiency was similar to that 
of the general population.
21 Mutlu, A. et al. 2011 Cross 
sectional study
•	Evaluated 120 children and adolescents (aged 3-20) 
levels of 25OHD, Parathyroid hormone, and Alkaline 
phosphatase, as well as A1c and daily insulin requirements. 
•	Controls were more likely to be Vitamin D deficient, 
compared to only 21.7% T1DM patients. 
•	There were no correlations between insulin requirements 
and 25OHD level. 
22 Zipitis, C.S. and 
A.K. Akobeng
2008 Meta-analysis •	Total number of participants was 1429 cases and 5026 
controls
Data from the case control studies showed risk of T1DM was 
significantly reduced in infants who were supplemented with 
Vitamin D compared to those who were not (pooled odds 
ratio 0.71, 95% CI 0.60 to 0.84)
23 Hypponen, E. et 
al.
2001 Birth cohort 
study
•	10,821 children were included in the analysis and followed 
up at one year
 Vitamin D supplementation was associated with a decreased 
frequency of T1DM. 
•	Regular vs no supplementation 0.12 (95% CI 0.03-0.51) 
and irregular vs no supplementation 0.16 (95% CI 0.04-
0.74) 
•	Children who regularly took the supplementation had a RR 
of 0.22 (0.05-0.89) compared to those that received less 
than the recommended amount. 
24 Brekke, H.K. and 
J. Ludvigsson
2007 Birth cohort 
study
•	16,070 infants were included at birth, and 11,081 and 8805 
at 1 and 2.5 years, respectively
•	Use of vitamin D associated supplements during 
pregnancy was associated with a reduced diabetes related 
autoimmunity at 1 yr (adjusted odds ratio 0.707, p=0.028), 
but not at 2.5 years
25 Greer, R.M. et al. 2007 Retrospective •	Children and adolescents with diabetes were more than 3x 
as likely to have vitamin D deficiency as those in the control 
group
26 Svoren, B.M. et 
al.
2009 Cross 
sectional study
•	25OHD3 was measured in 128 youth with T1DM
•	The majority of youth with T1DM had inadequate levels: 
insufficiency (61%) or deficiency (15%), with only 24% 
being sufficient. 
•	Participants with Vitamin D deficiency were significantly 
older (p<0.001) and had a longer diabetes disease duration 
(p<0.01) and had lower HbA1c (p=0.05)
27 Frazer, T.E. et al. 1981 •	45 white insulin dependent age 7-18yr diabetics
•	Circulating 24,25OH2D3 was significantly elevated and 
1,25OH2D3 was significantly decreased. 
•	The increase in 24,25OH2D3 was seen in diabetics with the 
most severe bone loss and maximally increased during the 
first 5 years of disease
28 Kaur, H. et al. 2011 Cross 
sectional study
•	Vitamin D levels were measured in 517 patients age 8-20
•	Retinopathy was more prevalent in patients with vitamin D 
deficiency (18 vs. 9%, p=0.02). 
•	In logistic regression, retinopathy was associated with 
vitamin D deficiency (odds ratio 2.12 CI 1.03-4.33), 
diabetes duration (1.13, 1.05-1.23), and HbA1c (1.24, 
1.02-1.50). 
REFERENCE AUTHOR YEAR DESIGN FINDINGS
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vitamin D levels and T1DM, one 
study showed that vitamin D 
deficiency was higher in healthy 
controls as compared to diabetics.21
The preponderance of evidence 
demonstrates that vitamin D 
deficiency is apparent at the time 
of diagnosis of T1DM, as well 
as throughout the course of the 
disease. This has led to additional 
studies attempting to determine 
whether supplementation could 
potentially prevent TIDM. A 
systematic review and meta-analysis 
sought to determine whether or 
not the development of T1DM 
was associated with a lack of 
vitamin D supplementation.22 This 
analysis showed that the risk of 
T1DM was significantly reduced in 
infants supplemented with vitamin 
D compared to infants who were 
not (pooled odds ratio 0.71, 95% 
CI 0.60 to 0.84). The study also 
showed some evidence of a dose 
response, but further research is 
needed to confirm this finding. A 
birth cohort study in Finland was 
done to determine whether dietary 
vitamin D supplementation was 
associated with a reduced risk of 
T1DM.23 Serum levels were analyzed 
at birth and again at one year in 
10,821 children. Supplementation 
was associated with a significantly 
decreased occurrence of 
T1DM. Children who took any 
supplementation, regardless of dose, 
had a lower rate of development of 
T1DM than children who receive 
no supplementation. Regular 
supplementation (400IU) was 
associated with an 80% reduction 
of the risk for development of 
T1DM.17 The EURODIAB case 
control study compared 800 T1DM 
children to 2000 healthy controls 
and also found that supplementation 
of vitamin D in infancy decreased 
the risk of T1DM.4 The effect was 
most obvious in patients with a later 
onset of disease. Notably those 
who received supplementation for 
one year or less showed a similar 
reduction in risk as compared to 
those with supplementation for a 
year or longer. Lastly, a study of 
vitamin D supplementation during 
infancy with follow up at 1 and 2.5 
years was performed to determine 
the effects of supplementation on 
development of T1DM. This study 
also looked at whether consumption 
of vitamin D during pregnancy 
had an effect on development of 
disease in the child.23 The use of a 
vitamin D containing supplement 
during pregnancy was associated 
with a reduction of diabetes related 
autoimmunity at 1 year of age, but 
no difference at 2.5 years of age. 
Vitamin D deficiency remains 
present throughout the course of 
the disease and in some cases will 
actually worsen as the duration 
of illness lengthens. This leads 
one to consider whether vitamin 
D supplementation is important 
in the management of those 
already diagnosed. A matched 
case control study evaluated the 
extent of vitamin D deficiency in 
populations of children already 
diagnosed with T1DM.15 This study 
showed that vitamin D deficiency 
was considerably higher in T1DM 
children (90.6%) compared to non-
diabetic children (85.6%). A similar 
Australian study demonstrated 
that children and adolescents with 
T1DM were three times more likely 
to have a deficiency of vitamin D as 
compared to the control group.25 A 
cross sectional study of adolescents 
with T1DM determined that 
participants with a longer duration 
since diagnosis had more severe 
vitamin D deficiency.26 In patients 
with a preexisting diagnosis of 
T1DM, circulating levels of inactive 
24, 25-(OH) 2D concentrations were 
significantly elevated; whereas active 
1, 25-(OH) 2D3 was significantly 
decreased. The increase in levels of 
24, 25-(OH) 2D was more severe in 
diabetics with significant bone loss. It 
was also maximally increased during 
the first 5 years of clinical disease.27 
Since vitamin D may confer 
protection through anti-inflammatory 
effects, retinopathy is a possible 
complication in diabetics, especially 
with insufficient vitamin D levels.28 
In a cross sectional study of 157 
adolescents aged 8-20 attending 
diabetes complications assessment 
services, retinopathy was more 
common in young adults with T1DM 
than controls. These results were 
independent of duration of illness 
or hemoglobin AIC (HgbA1C). 
Discussion
Although there is no vitamin D 
level that has been established 
as either protective or predictive 
for the development of T1DM, 
multiple studies have demonstrated 
the importance of vitamin D 
supplementation early in infancy and 
childhood and its preventative effects 
on autoimmune disease. Nearly 
all of the studies in this review 
mention that vitamin D acts through 
immunomodulation and can be 
preventative in the development of 
Type 1 diabetes. Some studies have 
indicated a possible dose dependent 
response when supplemented 
in infancy with a greater effect of 
supplementation from 7-12 months 
of age versus birth to 6 months.22
Another direction of research 
focuses on whether some individuals 
are genetically predisposed to a 
vitamin D deficiency, therefore at 
greater risk of T1DM. Vitamin D 
gene receptor polymorphisms have 
been linked to T1DM that may 
interfere with absorption of Vitamin 
D in the gut.6 Normally, vitamin D 
leads to a reduction of lymphocyte 
proliferation and cytokine 
production in the gut mucosa. 
Early in infancy, vitamin D helps in 
the development and maturation 
of the gut mucosa and limits the 
exposure to large molecular weight 
proteins with potentially antigenic 
properties, such as cow’s milk. 
Thus susceptible individuals may 
not be able to adequately absorb 
vitamin D in their diets due to the 
genetic predisposition leading to 
T1DM. However, further research 
is needed to determine the impact 
of this possible genetic link.
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Conclusion
In conclusion, an overwhelming 
amount of evidence has shown 
that vitamin D deficiency may be 
implicated in the development 
of T1DM in the pediatric 
population. Furthermore, vitamin 
D supplementation early in life 
has shown to be protective 
against the development of the 
disease. However, further research 
is needed to determine the 
significance of vitamin D levels and 
supplementation on development 
and course of T1DM. Evidence of 
effective dosage of supplementation 
as well as duration is needed to 
develop a standard of care for the 
prevention of this disease. Although 
the research is inconclusive, it is 
clear that vitamin D supplementation 
is recommended and even a modest 
dose may be beneficial. In light 
of the fact that Type 1 diabetes is 
increasing in our pediatric population 
in West Virginia, it seems we should 
at least ensure that we are giving 
the dosage of vitamin D currently 
recommended by the AAP. 
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